National, State and Territory Cancer Councils
Government cancer sites
Clinical trial information
- COSA/CCTG Clinical Trials Fact Sheet
- Australasian Gastro-Intestinal Trials Group (AGITG)
- Australasian Leukaemia & Lymphoma Group (ALLG)
- Australia & New Zealand Sarcoma Association (ANZSA)
- Australian and New Zealand Children's Haematology/Oncology Group (ANZCHOG)
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
- Australia New Zealand Gynaecological Oncology Group (ANZGOG)
- Australian New Zealand Clinical Trials Registry (ANZCTR)
- Breast Cancer Trials (BCT)
- Cancer Symptom Trials (CST)
- Cooperative Trials Group for Neuro-Oncology (COGNO)
- Melanoma and Skin Cancer Trials Ltd (MASC Trials)
- NHMRC Clinical Trials Centre
- Primary Care Collaborative Cancer Clinical Trials Group (PC4)
- Psycho-oncology Cooperative Research Group (PoCoG)
- Thoracic Oncology Group of Australasia (TOGA)
- TROG Cancer Research (TROG)
Consumer sites
Other sites
International
- American Congress of Obstetricians and Gynecologists (ACOG)
- American Society of Clinical Oncology (ASCO)
- Cancer.net - doctor-approved patient information from ASCO
- European Society of Medical Oncology (ESMO)
- International Psycho-Oncology Society (IPOS)
- National Cancer Institute (NCI)
- Southwest Oncology Group (SWOG)
- Union for International Cancer Control (UICC)
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 2 days ago
RT by @cosaoncology: 👁️ The 2024 Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit program is now available! 5 International speakers 11 Australian #ocularmelanoma experts 4 Ocular melanoma consumers Sat 15 June - Registration is free! Watch from anywhere worldwide! masc.org.au/aoma-summit/
Read More >COSAoncology 4 days ago
RT by @cosaoncology: 🚨Survivorship Care for People affected by Advanced or Metastatic Cancer🚨 💥 MASCC-ASCO Standards / Practice Recommendations now published💥 ‼️ Clinical tools online ‼️ 14 languages (coming soon) Co-published open access: ascopubs.org/doi/full/10.12… and link.springer.com/article/10.100…
Read More >COSAoncology 5 days ago
Last chance to save! Join or renew your COSA membership before 30 April 2024 to secure the 2023 member rate before they increase for 2024: bit.ly/3hXsDLm
Read More >COSAoncology 8 days ago
Missed the earlybird pricing for the COSA Cancer Pharmacists Group Education Program? You can still save if you join COSA or renew your membership before 30 April 2024! Members save on CPG registration fees - bit.ly/3aNqaSr
Read More >COSAoncology 8 days ago
COSA Groups create spaces to share ideas and information, work on projects and research, and contribute to COSA Council. To stay updated, make sure you update your Groups preferences when you renew your COSA membership. More: bit.ly/3emnboq
Read More >COSAoncology 10 days ago
RT by @cosaoncology: 🎙️Join Kim Hobbs at the Redefining Survivorship webinar! From navigating uncertainty to addressing financial burden and psychological challenges, Kim will offer invaluable advice for supporting people with treatable, but not curable cancers. Register here: tinyurl.com/yc89zvmk
Read More >COSAoncology 10 days ago
COSA's April eNews is in members' inboxes now ... ... and available to COSA members at bit.ly/4aNLTG6
Read More >COSAoncology 11 days ago
It only takes a few minutes to join COSA – Don't forget if you join by 30 April 2024 you will get bonus months of membership, and save on member rates before prices increase for 2024! Join now: bit.ly/3hXsDLm
Read More >COSAoncology 12 days ago
These steps show how to renew your COSA membership. Are you a nurse, have you been a student or in training and need to change your member type? Login first, then go to member types to select your new category: bit.ly/3s5mOC6
Read More >COSAoncology 16 days ago
COSA Groups reflect an interest in a tumour stream or specific cancer, age group, area, discipline or movement. When you join COSA, you can opt in to any number of Groups to reflect your specific interests in COSA. More: bit.ly/3emnboq
Read More >